Literature DB >> 30078640

An alternative transcript of the Alzheimer's disease risk gene SORL1 encodes a truncated receptor.

Jenny Blechingberg1, Annemarie Svane Aavild Poulsen1, Mads Kjølby2, Giulia Monti1, Mariet Allen3, Anne Kathrine Ivarsen1, Sarah J Lincoln3, Gangadaar Thotakura3, Christian B Vægter1, Nilüfer Ertekin-Taner3, Anders Nykjær4, Olav M Andersen5.   

Abstract

SORL1 encodes a 250-kDa protein named sorLA, a functional sorting receptor for the amyloid precursor protein (APP). Several single nucleotide polymorphisms of the gene SORL1, encoding sorLA, are genetically associated with Alzheimer's disease (AD). In the existing literature, SORL1 is insufficiently described at the transcriptional level, and there is very limited amount of functional data defining different transcripts. We have characterized a SORL1 transcript containing a novel exon 30B. The transcript is expressed in most brain regions with highest expression in the temporal lobe and hippocampus. Exon 30B is spliced to exon 31, leading to a mature transcript that encodes an 829 amino acid sorLA receptor. This receptor variant lacks the binding site for APP and is unlikely to function in APP sorting. This transcript is expressed in equal amounts in the cerebellum from AD and non-AD individuals. Our data describe a transcript that encodes a truncated sorLA receptor, suggesting novel neuronal functions for sorLA and that alternative transcription provides a mechanism for SORL1 activity regulation.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alternative transcription; Alzheimer's disease risk gene; Exon 30B; SORL1; SorLA

Mesh:

Substances:

Year:  2018        PMID: 30078640      PMCID: PMC6769419          DOI: 10.1016/j.neurobiolaging.2018.06.021

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  65 in total

1.  Unique expression pattern of a novel mosaic receptor in the developing cerebral cortex.

Authors:  I Hermans-Borgmeyer; W Hampe; B Schinke; A Methner; A Nykjaer; U Süsens; U Fenger; B Herbarth; H C Schaller
Journal:  Mech Dev       Date:  1998-01       Impact factor: 1.882

2.  SorLA complement-type repeat domains protect the amyloid precursor protein against processing.

Authors:  Arnela Mehmedbasic; Sofie K Christensen; Jonas Nilsson; Ulla Rüetschi; Camilla Gustafsen; Annemarie Svane Aavild Poulsen; Rikke W Rasmussen; Anja N Fjorback; Göran Larson; Olav M Andersen
Journal:  J Biol Chem       Date:  2014-12-18       Impact factor: 5.157

3.  Identification of a novel exon in apolipoprotein E receptor 2 leading to alternatively spliced mRNAs found in cells of the vascular wall but not in neuronal tissue.

Authors:  I Korschineck; S Ziegler; J Breuss; I Lang; M Lorenz; C Kaun; P F Ambros; B R Binder
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

4.  The DegraBase: a database of proteolysis in healthy and apoptotic human cells.

Authors:  Emily D Crawford; Julia E Seaman; Nick Agard; Gerald W Hsu; Olivier Julien; Sami Mahrus; Huy Nguyen; Kazutaka Shimbo; Hikari A I Yoshihara; Min Zhuang; Robert J Chalkley; James A Wells
Journal:  Mol Cell Proteomics       Date:  2012-12-20       Impact factor: 5.911

Review 5.  An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1987-10-26       Impact factor: 16.971

6.  SorLA controls neurotrophic activity by sorting of GDNF and its receptors GFRα1 and RET.

Authors:  Simon Glerup; Maria Lume; Ditte Olsen; Jens R Nyengaard; Christian B Vaegter; Camilla Gustafsen; Erik I Christensen; Mads Kjolby; Anders Hay-Schmidt; Dirk Bender; Peder Madsen; Mart Saarma; Anders Nykjaer; Claus M Petersen
Journal:  Cell Rep       Date:  2013-01-17       Impact factor: 9.423

7.  SorLA/LR11 regulates processing of amyloid precursor protein via interaction with adaptors GGA and PACS-1.

Authors:  Vanessa Schmidt; Anje Sporbert; Michael Rohe; Tatjana Reimer; Armin Rehm; Olav M Andersen; Thomas E Willnow
Journal:  J Biol Chem       Date:  2007-09-12       Impact factor: 5.157

8.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

9.  GGA1-mediated endocytic traffic of LR11/SorLA alters APP intracellular distribution and amyloid-β production.

Authors:  Jeremy H Herskowitz; Katrin Offe; Aniruddha Deshpande; Richard A Kahn; Allan I Levey; James J Lah
Journal:  Mol Biol Cell       Date:  2012-05-23       Impact factor: 4.138

10.  Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP).

Authors:  C Reitz; G Tosto; B Vardarajan; E Rogaeva; M Ghani; R S Rogers; C Conrad; J L Haines; M A Pericak-Vance; M D Fallin; T Foroud; L A Farrer; G D Schellenberg; P S George-Hyslop; R Mayeux
Journal:  Transl Psychiatry       Date:  2013-05-14       Impact factor: 6.222

View more
  3 in total

Review 1.  Sequence and Evolutionary Features for the Alternatively Spliced Exons of Eukaryotic Genes.

Authors:  Shi-Yi Chen; Cao Li; Xianbo Jia; Song-Jia Lai
Journal:  Int J Mol Sci       Date:  2019-08-06       Impact factor: 5.923

2.  A genetically modified minipig model for Alzheimer's disease with SORL1 haploinsufficiency.

Authors:  Olav M Andersen; Nikolaj Bøgh; Anne M Landau; Gro G Pløen; Anne Mette G Jensen; Giulia Monti; Benedicte P Ulhøi; Jens R Nyengaard; Kirsten R Jacobsen; Margarita M Jørgensen; Ida E Holm; Marianne L Kristensen; Aage Kristian O Alstrup; Esben S S Hansen; Charlotte E Teunissen; Laura Breidenbach; Mathias Droescher; Ying Liu; Hanne S Pedersen; Henrik Callesen; Yonglun Luo; Lars Bolund; David J Brooks; Christoffer Laustsen; Scott A Small; Lars F Mikkelsen; Charlotte B Sørensen
Journal:  Cell Rep Med       Date:  2022-09-12

3.  Expression of an alternatively spliced variant of SORL1 in neuronal dendrites is decreased in patients with Alzheimer's disease.

Authors:  Giulia Monti; Mads Kjolby; Anne Mette G Jensen; Mariet Allen; Juliane Reiche; Peter L Møller; Raquel Comaposada-Baró; Bartlomiej E Zolkowski; Cármen Vieira; Margarita Melnikova Jørgensen; Ida E Holm; Paul N Valdmanis; Niels Wellner; Christian B Vægter; Sarah J Lincoln; Anders Nykjær; Nilüfer Ertekin-Taner; Jessica E Young; Mette Nyegaard; Olav M Andersen
Journal:  Acta Neuropathol Commun       Date:  2021-03-16       Impact factor: 7.578

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.